Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women

Muhammad Faisal Aslam, Zaher O. Merhi, Safaa Ahmed, Oumar Kuzbari, David B. Seifer, Howard Minkoff

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and müllerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy.

Original languageEnglish (US)
Pages (from-to)1790-1793
Number of pages4
JournalFertility and sterility
Volume95
Issue number5
DOIs
StatePublished - Apr 1 2011

Keywords

  • Anti-müllerian hormone
  • brain-derived neurotrophic factor
  • cancer
  • chemotherapy
  • müllerian-inhibiting substance
  • ovarian reserve

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women'. Together they form a unique fingerprint.

  • Cite this